Isatuximab in Multiple Myeloma Posted on August 28, 2019November 19, 2019 by omnihelathmedia The addition of isatuximab to pomalidomide and low-dose dexamethasone significantly improved PFS and overall response rate among patients with relapsed or refractory multiple myeloma, according to ran... Read More
